# Official Journal C 165A/19 J

| | ISSN 1725-2423 |
| --- | --- |
| Official Journal
  of the European Union | C 165A |
| | |
| English edition | Information and Notices | Volume 5019 July 2007 |

ISSN 1725-2423

Official Journal

of the European Union

C 165A

English edition

Information and Notices

Volume 5019 July 2007

---

| Notice No | Contents | page |
| --- | --- | --- |
| | V   Announcements |
| | ADMINISTRATIVE PROCEDURES |
| | European Medicines Agency |
| 2007/C 165A/01 | Recruitment for the European Medicines Agency (London) | 1 |

Notice No

Contents

page

V   Announcements

ADMINISTRATIVE PROCEDURES

European Medicines Agency

2007/C 165A/01

Recruitment for the European Medicines Agency (London)

1

| | Corrigenda |
| --- | --- |
| 2007/C 165A/02 | Corrigendum to Notice EMEA/AD/241 Administrator (Scientific), Pharmacovigilance, Unit for the Post-Authorisation Evaluation of Medicines for Human Use (AD5) (OJ C 254 A, 20.10.2006) | 3 |

Corrigenda

2007/C 165A/02

Corrigendum to Notice EMEA/AD/241 Administrator (Scientific), Pharmacovigilance, Unit for the Post-Authorisation Evaluation of Medicines for Human Use (AD5) (OJ C 254 A, 20.10.2006)

3

| EN | |
| --- | --- |

EN

---

V Announcements

ADMINISTRATIVE PROCEDURES

European Medicines Agency

| 19.7.2007 | EN | Official Journal of the European Union | CA 165/1 |
| --- | --- | --- | --- |

19.7.2007

EN

Official Journal of the European Union

CA 165/1

---

RECRUITMENT FOR THE EUROPEAN MEDICINES AGENCY (LONDON)

(2007/C 165 A/01)

The Agency is responsible for coordinating the evaluation and supervision of medicinal products for human and veterinary use in the European Union (see European Parliament and Council Regulation (EC) No 726/2004 of 31 March 2004 (1)). The EMEA was established in January 1995. It has many close contacts with the European Commission, 27 EU Member States, EEA-EFTA countries and many other groups in government and the private sector.

Further information on the EMEA and its activities is readily accessible through the Internet; our web address is http://www.emea.europa.eu

The European Medicines Agency is organising selection procedures with a view to drawing up reserve lists for:

| — | EMEA/AD/246: Administrator (Scientific), Medical Information Sector (AD7) |
| --- | --- |

—

EMEA/AD/246: Administrator (Scientific), Medical Information Sector (AD7)

| — | EMEA/AD/247: Specialised Group Leader in Oracle Database Administration (AD8) |
| --- | --- |

—

EMEA/AD/247: Specialised Group Leader in Oracle Database Administration (AD8)

| — | EMEA/AD/248: Administrator, Legal Sector (AD5) |
| --- | --- |

—

EMEA/AD/248: Administrator, Legal Sector (AD5)

| — | EMEA/AD/249: Administrator (Scientific), Pharmacovigilance, Unit for Post-Authorisation Evaluation of Medicines for Human Use (AD8) |
| --- | --- |

—

EMEA/AD/249: Administrator (Scientific), Pharmacovigilance, Unit for Post-Authorisation Evaluation of Medicines for Human Use (AD8)

| — | EMEA/AST/250: Assistant, Pharmacovigilance and Post-Authorisation Safety and Efficacy of Human Medicines Sector, Unit for the Post-Authorisation Evaluation of Medicines for Human Use (AST3) |
| --- | --- |

—

EMEA/AST/250: Assistant, Pharmacovigilance and Post-Authorisation Safety and Efficacy of Human Medicines Sector, Unit for the Post-Authorisation Evaluation of Medicines for Human Use (AST3)

| — | EMEA/AD/251: Specialised Group Leader in anti-infective, Unit for the Pre-authorisation Evaluation of Medicines for Human Use (AD8) |
| --- | --- |

—

EMEA/AD/251: Specialised Group Leader in anti-infective, Unit for the Pre-authorisation Evaluation of Medicines for Human Use (AD8)

| — | EMEA/AD/252: Administrator (Scientific), Safety and Efficacy and Scientific Advice and Orphan Drugs, Unit for the Pre-Authorisation Evaluation of Medicines for Human Use (AD5) |
| --- | --- |

—

EMEA/AD/252: Administrator (Scientific), Safety and Efficacy and Scientific Advice and Orphan Drugs, Unit for the Pre-Authorisation Evaluation of Medicines for Human Use (AD5)

| — | EMEA/AD/253: Administrator (Scientific), Business Pipeline, Safety and Efficacy, Unit for the Pre-Authorisation Evaluation of Medicines for Human Use (AD8) |
| --- | --- |

—

EMEA/AD/253: Administrator (Scientific), Business Pipeline, Safety and Efficacy, Unit for the Pre-Authorisation Evaluation of Medicines for Human Use (AD8)

Selected candidates will be included on a reserve list and, depending on the budgetary situation, may be offered a five-year renewable contract in accordance with the Conditions of employment of other servants of the European Communities (2)
  (Official Journal of the European Communities No L  56 of 4 March 1968).

The place of employment shall be London.

Candidates must be nationals of a Member State of the European Communities, or of Iceland, Norway or Liechtenstein, on condition that they have full rights as a citizen.

The complete conditions and job description should be downloaded from the EMEA website:http://www.emea.europa.eu/htms/general/admin/recruit/recruitnew.htmApplications must be made electronically using the form available on the EMEA website. Applications must be sent no later than midnight on 30 August 2007.Please note that due to the large numbers of applications EMEA receives, when reaching the deadline for submission of applications, the system may have problems to process the large amounts of data. Applicants are therefore advised to send in their application well ahead of the deadline.

If you wish to receive notification of vacancy publications electronically please register online at http://www.emea.europa.eu/under ‘Online Mailing Service’.

---

(1)  OJ L 136, 30.4.2004, p. 1. Regulation as last amended by Regulation (EC) No 1901/2006 (OJ L 378, 27.12.2006, p. 1).

(2)  Regulation (EEC, Euratom, ECSC) No 259/68 of the Council of 29 February 1968 laying down the Staff Regulations of Officials and the Conditions of employment of other servants of the European Communities and instituting special measures temporarily applicable to officials of the Commission (OJ L 56, 4.3.1968, p. 1). Regulation as last amended by Regulation (EC, Euratom) No 1895/2006 (OJ L 397, 30.12.2006, p. 6).

---

Corrigenda

| 19.7.2007 | EN | Official Journal of the European Union | CA 165/3 |
| --- | --- | --- | --- |

19.7.2007

EN

Official Journal of the European Union

CA 165/3

---

Corrigendum to Notice EMEA/AD/241 Administrator (Scientific), Pharmacovigilance, Unit for the Post-Authorisation Evaluation of Medicines for Human Use (AD5)

(
  Official Journal of the European Union C 254 A of 20 October 2006
  )

(2007/C 165 A/02)

After the date on which the above notice was published, the EMEA decided to cancel the selection procedure EMEA/AD/241 Administrator (Scientific), Pharmacovigilance, Unit for the Post-Authorisation Evaluation of Medicines for Human Use (AD5) as EMEA requirements have changed.

---